218 related articles for article (PubMed ID: 20825246)
1. Structural analysis of a highly glycosylated and unliganded gp120-based antigen using mass spectrometry.
Wang L; Qin Y; Ilchenko S; Bohon J; Shi W; Cho MW; Takamoto K; Chance MR
Biochemistry; 2010 Oct; 49(42):9032-45. PubMed ID: 20825246
[TBL] [Abstract][Full Text] [Related]
2. Structure of a V3-containing HIV-1 gp120 core.
Huang CC; Tang M; Zhang MY; Majeed S; Montabana E; Stanfield RL; Dimitrov DS; Korber B; Sodroski J; Wilson IA; Wyatt R; Kwong PD
Science; 2005 Nov; 310(5750):1025-8. PubMed ID: 16284180
[TBL] [Abstract][Full Text] [Related]
3. Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition.
Koch M; Pancera M; Kwong PD; Kolchinsky P; Grundner C; Wang L; Hendrickson WA; Sodroski J; Wyatt R
Virology; 2003 Sep; 313(2):387-400. PubMed ID: 12954207
[TBL] [Abstract][Full Text] [Related]
4. Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity.
Rathore U; Saha P; Kesavardhana S; Kumar AA; Datta R; Devanarayanan S; Das R; Mascola JR; Varadarajan R
J Biol Chem; 2017 Jun; 292(24):10197-10219. PubMed ID: 28446609
[TBL] [Abstract][Full Text] [Related]
5. Local conformational stability of HIV-1 gp120 in unliganded and CD4-bound states as defined by amide hydrogen/deuterium exchange.
Kong L; Huang CC; Coales SJ; Molnar KS; Skinner J; Hamuro Y; Kwong PD
J Virol; 2010 Oct; 84(19):10311-21. PubMed ID: 20660185
[TBL] [Abstract][Full Text] [Related]
6. Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type 1 glycoprotein 120 by N-linked oligosaccharides in the V1 region.
Losman B; Bolmstedt A; Schønning K; Björndal A ; Westin C; Fenyö EM; Olofsson S
AIDS Res Hum Retroviruses; 2001 Jul; 17(11):1067-76. PubMed ID: 11485624
[TBL] [Abstract][Full Text] [Related]
7. Identification of an N-linked glycan in the V1-loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4.
Gram GJ; Hemming A; Bolmstedt A; Jansson B; Olofsson S; Akerblom L; Nielsen JO; Hansen JE
Arch Virol; 1994; 139(3-4):253-61. PubMed ID: 7832633
[TBL] [Abstract][Full Text] [Related]
8. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
[TBL] [Abstract][Full Text] [Related]
9. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
[TBL] [Abstract][Full Text] [Related]
10. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
[TBL] [Abstract][Full Text] [Related]
11. NMR structure of an anti-gp120 antibody complex with a V3 peptide reveals a surface important for co-receptor binding.
Tugarinov V; Zvi A; Levy R; Hayek Y; Matsushita S; Anglister J
Structure; 2000 Apr; 8(4):385-95. PubMed ID: 10801487
[TBL] [Abstract][Full Text] [Related]
12. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
Chakraborty K; Durani V; Miranda ER; Citron M; Liang X; Schleif W; Joyce JG; Varadarajan R
Biochem J; 2006 Nov; 399(3):483-91. PubMed ID: 16827663
[TBL] [Abstract][Full Text] [Related]
13. Structural dynamics of HIV-1 envelope Gp120 outer domain with V3 loop.
Yokoyama M; Naganawa S; Yoshimura K; Matsushita S; Sato H
PLoS One; 2012; 7(5):e37530. PubMed ID: 22624045
[TBL] [Abstract][Full Text] [Related]
14. Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization.
Rosen O; Chill J; Sharon M; Kessler N; Mester B; Zolla-Pazner S; Anglister J
Biochemistry; 2005 May; 44(19):7250-8. PubMed ID: 15882063
[TBL] [Abstract][Full Text] [Related]
15. Expression-system-dependent modulation of HIV-1 envelope glycoprotein antigenicity and immunogenicity.
Kong L; Sheppard NC; Stewart-Jones GBE; Robson CL; Chen H; Xu X; Krashias G; Bonomelli C; Scanlan CN; Kwong PD; Jeffs SA; Jones IM; Sattentau QJ
J Mol Biol; 2010 Oct; 403(1):131-147. PubMed ID: 20800070
[TBL] [Abstract][Full Text] [Related]
16. Glycosylation affects both the three-dimensional structure and antibody binding properties of the HIV-1IIIB GP120 peptide RP135.
Huang X; Barchi JJ; Lung FD; Roller PP; Nara PL; Muschik J; Garrity RR
Biochemistry; 1997 Sep; 36(36):10846-56. PubMed ID: 9312273
[TBL] [Abstract][Full Text] [Related]
17. Expression, glycoform characterization, and antibody-binding of HIV-1 V3 glycopeptide domain fused with human IgG1-Fc.
Yang Q; Li C; Wei Y; Huang W; Wang LX
Bioconjug Chem; 2010 May; 21(5):875-83. PubMed ID: 20369886
[TBL] [Abstract][Full Text] [Related]
18. Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop.
Stanfield RL; Ghiara JB; Ollmann Saphire E; Profy AT; Wilson IA
Virology; 2003 Oct; 315(1):159-73. PubMed ID: 14592768
[TBL] [Abstract][Full Text] [Related]
19. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding.
Rizzuto CD; Wyatt R; Hernández-Ramos N; Sun Y; Kwong PD; Hendrickson WA; Sodroski J
Science; 1998 Jun; 280(5371):1949-53. PubMed ID: 9632396
[TBL] [Abstract][Full Text] [Related]
20. Structural Analysis of the Glycosylated Intact HIV-1 gp120-b12 Antibody Complex Using Hydroxyl Radical Protein Footprinting.
Li X; Grant OC; Ito K; Wallace A; Wang S; Zhao P; Wells L; Lu S; Woods RJ; Sharp JS
Biochemistry; 2017 Feb; 56(7):957-970. PubMed ID: 28102671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
